{"id":"NCT01682863","sponsor":"Novartis Pharmaceuticals","briefTitle":"A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation","officialTitle":"A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10","primaryCompletion":"2014-06","completion":"2014-06","firstPosted":"2012-09-11","resultsPosted":"2016-03-30","lastUpdate":"2016-03-30"},"enrollment":614,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"QVA149","otherNames":[]},{"type":"DRUG","name":"QVA149","otherNames":[]},{"type":"DRUG","name":"QAB149","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"QVA149 dose 1","type":"EXPERIMENTAL"},{"label":"QVA149 dose 2","type":"EXPERIMENTAL"},{"label":"QAB149","type":"ACTIVE_COMPARATOR"}],"summary":"This study is to assess the safety and tolerability of two different doses of QVA149 and QAB149 in patients with moderate to severe airflow limitation.","primaryOutcome":{"measure":"Number of Patients With Adverse Events, Serious Adverse Events, and Death","timeFrame":"56 weeks","effectByArm":[{"arm":"QVA149 27.5/12.5 ug Bid","deltaMin":26,"sd":null},{"arm":"QVA149 27.5/25 ug Bid","deltaMin":25,"sd":null},{"arm":"QAB149 75 ug od","deltaMin":24,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":86,"countries":["United States","Bulgaria","Finland","Hungary","Puerto Rico","Romania","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":26,"n":204},"commonTop":["CHRONIC OBSTRUCTIVE PULMONARY DISEASE","NASOPHARYNGITIS","UPPER RESPIRATORY TRACT INFECTION BACTERIAL","UPPER RESPIRATORY TRACT INFECTION","COUGH"]}}